Redeye initiates coverage of BiBBInstruments, a medtech company developing the EndoDrill biopsy platform. Following several years of product development and regulatory work, EndoDrill GI is now entering commercialisation in the US and Europe. While still at an early stage, the coming years should provide a much clearer picture of the commercial potential of EndoDrill GI and could reveal further long-term value in the broader platform.
LÄS MER
